In December Pfizer might apply its vaccine in Mexico: Ebrard

In the event that Cofepris approves it, the Pfizer vaccine could be used in 17 million Mexicans next month.

Grow your business, Not your inbox

Stay up to date and subscribe to our daily newsletter now!

November 25, 2020 3 min read

This article has been translated from our Spanish edition using AI technologies. Errors can occur due to this process.

The Secretary for Foreign Relations Marcelo ebrad pointed out this week that in the event that the Federal Commission for the Protection against Health Risks (Cofepris) approves the vaccine against COVID-19 from Pfizer could be used by 17 million Mexicans next December.

Vaccination Report: Pfizer will arrive in Mexico this December, provided COFEPRIS is approved. Cansino is already in phase III of 15,000 volunteers. AztraZeneca Oxford for the start of production. Dr. Alcocer already has an operational vaccination schedule. We will contact you !!

– Marcelo Ebrard C. (@m_ebrard), November 24, 2020

This after the pharmaceutical company announced that its vaccine has an efficacy rate of 95% (including older adults) and has applied for required approval from the US Food Drug Administration (FDA) to begin marketing.

Likewise, the secretary stated, “If the regulator believes it can be approved, as we hope it will be approved in the US and Europe, Mexico will begin its process in December as well.” This way, “it will arrive in Mexico on the third day, the fourth day is the customs clearance process; It is sent to the distribution centers between the fourth and fifth day to finally reach the vaccination points indicated by the Ministry of Health. “

Let us remember that this vaccine consists of two doses and, in accordance with the agreements with the Mexican government, it will be purchased in the quantities necessary to use it in seventeen million people.

Meanwhile, the Undersecretary of State for Prevention and Health Promotion Hugo López Gatell assured that Cofepris “will be serviced with a special device to facilitate the whole process immediately”. So he added: “We really want that in the case of Pfizer and CanSino will be ready in December” so that they can be distributed.

At CanSino, according to Marcelo Ebrad, the collaboration of fifteen thousand volunteers is necessary so that the third phase of the relevant clinical studies can be carried out. For this reason, eight other centers have already been authorized to carry out the corresponding tests.

Comments are closed.